176 related articles for article (PubMed ID: 2601256)
1. Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).
Van Cutsem J; Boelaert JR
Kidney Int; 1989 Dec; 36(6):1061-8. PubMed ID: 2601256
[TBL] [Abstract][Full Text] [Related]
2. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.
Boelaert JR; Van Cutsem J; de Locht M; Schneider YJ; Crichton RR
Kidney Int; 1994 Mar; 45(3):667-71. PubMed ID: 8196268
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.
Boelaert JR; de Locht M; Van Cutsem J; Kerrels V; Cantinieaux B; Verdonck A; Van Landuyt HW; Schneider YJ
J Clin Invest; 1993 May; 91(5):1979-86. PubMed ID: 8486769
[TBL] [Abstract][Full Text] [Related]
4. Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus.
de Locht M; Boelaert JR; Schneider YJ
Biochem Pharmacol; 1994 May; 47(10):1843-50. PubMed ID: 8204101
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Van Cutsem J; Van Gerven F; Fransen J; Janssen PA
Chemotherapy; 1989; 35(4):267-72. PubMed ID: 2548818
[TBL] [Abstract][Full Text] [Related]
6. Effect of ferrioxamine on the growth of Rhizopus.
Verdonck AK; Boelaert JR; Gordts BZ; Van Landuyt HW
Mycoses; 1993; 36(1-2):9-12. PubMed ID: 8316265
[TBL] [Abstract][Full Text] [Related]
7. Deferiprone iron chelation as a novel therapy for experimental mucormycosis.
Ibrahim AS; Edwards JE; Fu Y; Spellberg B
J Antimicrob Chemother; 2006 Nov; 58(5):1070-3. PubMed ID: 16928702
[TBL] [Abstract][Full Text] [Related]
8. Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine.
Liu M; Lin L; Gebremariam T; Luo G; Skory CD; French SW; Chou TF; Edwards JE; Ibrahim AS
PLoS Pathog; 2015 May; 11(5):e1004842. PubMed ID: 25974051
[TBL] [Abstract][Full Text] [Related]
9. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.
Ibrahim AS; Bowman JC; Avanessian V; Brown K; Spellberg B; Edwards JE; Douglas CM
Antimicrob Agents Chemother; 2005 Feb; 49(2):721-7. PubMed ID: 15673756
[TBL] [Abstract][Full Text] [Related]
11. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.
Nakamura M; Weil WB; Kaufman DB
Pediatr Nephrol; 1989 Jan; 3(1):80-2. PubMed ID: 2702092
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen as an adjunct in zygomycosis: randomized controlled trial in a murine model.
Barratt DM; Van Meter K; Asmar P; Nolan T; Trahan C; Garcia-Covarrubias L; Metzinger SE
Antimicrob Agents Chemother; 2001 Dec; 45(12):3601-2. PubMed ID: 11709348
[TBL] [Abstract][Full Text] [Related]
13. Survival from sino-orbital mucormycosis due to Rhizopus rhizopodiformis.
Rosenberger RS; West BC; King JW
Am J Med Sci; 1983; 286(3):25-30. PubMed ID: 6356916
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients.
Stivelman J; Schulman G; Fosburg M; Lazarus JM; Hakim RM
Kidney Int; 1989 Dec; 36(6):1125-32. PubMed ID: 2601259
[TBL] [Abstract][Full Text] [Related]
15. Effects of iron and desferrioxamine on Rhizopus infection.
Abe F; Inaba H; Katoh T; Hotchi M
Mycopathologia; 1990 May; 110(2):87-91. PubMed ID: 2142253
[TBL] [Abstract][Full Text] [Related]
16. Indolent zygomycosis associated with deferoxamine chelation therapy.
Prokopowicz GP; Bradley SF; Kauffman CA
Mycoses; 1994; 37(11-12):427-31. PubMed ID: 7659131
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
RodrÃguez MM; Serena C; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2008 Oct; 52(10):3786-8. PubMed ID: 18694953
[TBL] [Abstract][Full Text] [Related]
18. Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis.
Bottone EJ; Weitzman I; Hanna BA
J Clin Microbiol; 1979 Apr; 9(4):530-7. PubMed ID: 457856
[TBL] [Abstract][Full Text] [Related]
19. Treatment of experimental mucormycosis (Rhizopus oryzae infection) in rabbits with amphotericin B.
CHICK EW; EVANS J; BAKER RD
Antibiot Chemother (Northfield); 1958 Aug; 8(8):394-9. PubMed ID: 24544889
[No Abstract] [Full Text] [Related]
20. The iron chelator deferasirox protects mice from mucormycosis through iron starvation.
Ibrahim AS; Gebermariam T; Fu Y; Lin L; Husseiny MI; French SW; Schwartz J; Skory CD; Edwards JE; Spellberg BJ
J Clin Invest; 2007 Sep; 117(9):2649-57. PubMed ID: 17786247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
